XML 152 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
12 Months Ended
May 31, 2013
May 31, 2012
May 31, 2011
Cash provided by operations:      
Net income $ 2,485,000,000 $ 2,223,000,000 $ 2,133,000,000
Income charges (credits) not affecting cash:      
Depreciation 438,000,000 373,000,000 335,000,000
Deferred income taxes 21,000,000 (60,000,000) (76,000,000)
Stock-based compensation (Note 11) 174,000,000 130,000,000 105,000,000
Amortization and other 75,000,000 32,000,000 23,000,000
Net gain on divestitures (124,000,000) 0 0
Changes in certain working capital components and other assets and liabilities:      
Decrease (increase) in accounts receivable 142,000,000 (323,000,000) (273,000,000)
(Increase) in inventories (197,000,000) (805,000,000) (551,000,000)
(Increase) in prepaid expenses and other current assets (28,000,000) (141,000,000) (35,000,000)
Increase in accounts payable, accrued liabilities and income taxes payable 41,000,000 470,000,000 151,000,000
Cash provided by operations 3,027,000,000 1,899,000,000 1,812,000,000
Cash (used) provided by investing activities:      
Purchases of short-term investments (3,702,000,000) (2,705,000,000) (7,616,000,000)
Maturities of short-term investments 1,501,000,000 2,585,000,000 4,313,000,000
Sales of short-term investments 998,000,000 1,244,000,000 2,766,000,000
Additions to property, plant and equipment (636,000,000) (597,000,000) (432,000,000)
Disposals of property, plant and equipment 14,000,000 2,000,000 1,000,000
Proceeds from divestitures 786,000,000 0 0
Increase in other assets, net of other liabilities (28,000,000) (37,000,000) (30,000,000)
Settlement of net investment hedges 0 22,000,000 (23,000,000)
Cash (used) provided by investing activities (1,067,000,000) 514,000,000 (1,021,000,000)
Cash used by financing activities:      
Net proceeds from long-term debt issuance 986,000,000 0 0
Long-term debt payments, including current portion (49,000,000) (203,000,000) (8,000,000)
Increase (decrease) in notes payable 15,000,000 (65,000,000) 41,000,000
Proceeds from exercise of stock options and other stock issuances 313,000,000 468,000,000 345,000,000
Excess tax benefits from share-based payment arrangements 72,000,000 115,000,000 64,000,000
Repurchase of common stock (1,674,000,000) (1,814,000,000) (1,859,000,000)
Dividends — common and preferred (703,000,000) (619,000,000) (555,000,000)
Cash used by financing activities (1,040,000,000) (2,118,000,000) (1,972,000,000)
Effect of exchange rate changes 100,000,000 67,000,000 57,000,000
Net increase (decrease) in cash and equivalents 1,020,000,000 362,000,000 (1,124,000,000)
Cash and equivalents, beginning of year 2,317,000,000 1,955,000,000 3,079,000,000
CASH AND EQUIVALENTS, END OF YEAR 3,337,000,000 2,317,000,000 1,955,000,000
Cash paid during the year for:      
Interest, net of capitalized interest 20,000,000 29,000,000 32,000,000
Income taxes 702,000,000 638,000,000 736,000,000
Dividends declared and not paid $ 188,000,000 $ 165,000,000 $ 145,000,000